FRATES JAMES M Insider Trading Activity

Average Profitability
11.01%
Insider Buys Quantity
3
Insider Buys Sum
$291,102.62
Insider Sells Quantity
84
Insider Sells Sum
$57.08M

Insider Activity of FRATES JAMES M

According to the SEC Form 4 filings, FRATES JAMES M, being in a position of

  1. Chief Financial Officer at Amylyx Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25602 shares for $553,723,
    over all time since 2023-01-06, has bought 40000 shares for $101,368, and sold 119222 shares for $2.83M.

Biography of FRATES JAMES M

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $553,7234100

Comparison of Insiders on Amount of Buys and Sells

2026-09-10SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
10,810
0.0098%
$32.36$349,821-10.8%
2026-03-02SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
7,909
0.0091%
$14.52$114,851+16.14%
2026-02-02SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
3,557
0.0043%
$14.65$52,097+18.78%
2026-01-06SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
3,326
0.0039%
$11.11$36,954+48.68%
2025-09-30SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
10,558
0.0128%
$14.65$154,650+8.39%
2025-03-31SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
10,896
0.0121%
$3.47$37,806+241.24%
2024-09-12PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
40,000
0.0267%
$2.53$101,368+91.57%
2024-03-05SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
1,792
0.0088%
$18.73$33,560-84.72%
2024-01-09SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
2,716
0.0117%
$16.33$44,347-82.44%
2023-05-16SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
32,500
0.2305%
$26.94$875,451-37.99%
2023-03-16SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
32,500
0.2729%
$31.89$1.04M-38.87%
2023-01-06SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
2,658
0.0254%
$36.30$96,481-39.04%
2018-06-12SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
33,684
0.0218%
$50.00$1.68M-29.67%
2017-11-29SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
41,864
0.0267%
$50.51$2.11M-12.24%
2017-11-08SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
41,864
0.017%
$29.94$1.25M-4.6%
2017-03-07SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
50,000
0.0329%
$59.08$2.95M-4.12%
2016-12-14SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
50,000
0.0328%
$54.73$2.74M+0.97%
2016-12-07SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
47,462
0.0317%
$56.28$2.67M+0.13%
2015-11-10SaleAlkermes plc
ALKS
SVP & CFO, Alkermes plc
20,000
0.008%
$44.14$882,895-38.74%
2015-10-13SaleAlkermes plc
ALKS
SVP & CFO, Alkermes plc
40,000
0.0277%
$59.78$2.39M-21.04%
Total: 86
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.